L-Ala-Ala-Phe-7-Amido-4-methylcoumarin Tfa salt links a tripeptide to a fluorogenic reporter, enabling quantitative studies of protease activity. Phenylalanine enhances hydrophobic recognition, shaping enzymatic interactions. Researchers analyze its fluorescence output during cleavage reactions. Uses include kinetic profiling, substrate evaluation, and assay development.
CAT No: R2475
CAS No:62037-42-7
Synonyms/Alias:Ala-Ala-Phe-AMC (TFA);H-AAF-AMC,TFA;62037-42-7;L-Ala-Ala-Phe-7-Amido-4-methylcoumarin Tfa salt;HY-137164A;CS-1050127;(S)-2-((S)-2-((S)-2-aminopropanamido)propanamido)-N-(4-methyl-2-oxo-2H-chromen-7-yl)-3-phenylpropanamide 2,2,2-trifluoroacetate;
L-Ala-Ala-Phe-7-Amido-4-methylcoumarin Tfa salt is a synthetic peptide substrate that integrates a tripeptide sequence (L-alanyl-L-alanyl-L-phenylalanine) with a 7-amido-4-methylcoumarin (AMC) fluorogenic leaving group, presented as the trifluoroacetate salt. This compound is widely recognized in biochemical research for its utility in enzymology, particularly in the study of protease activity. The design of the peptide sequence and the AMC moiety enables sensitive detection of enzymatic cleavage events via fluorescence, making it a valuable tool for kinetic analyses, inhibitor screening, and mechanistic studies involving serine and cysteine proteases.
Enzyme Activity Assays: As a fluorogenic peptide substrate, L-Ala-Ala-Phe-AMC is extensively used to quantify the activity of specific proteases, such as chymotrypsin-like enzymes. Upon proteolytic cleavage at the peptide bond adjacent to the AMC group, the non-fluorescent substrate releases highly fluorescent AMC, allowing real-time monitoring of enzymatic reactions. This property facilitates accurate measurement of protease kinetics in both endpoint and continuous assays, supporting detailed characterization of enzyme specificity and catalytic efficiency.
Inhibitor Screening: The compound serves as a robust platform for high-throughput screening of protease inhibitors. The fluorescence-based readout provides a rapid and sensitive means to assess the potency and selectivity of candidate molecules that modulate protease function. By enabling efficient identification of active compounds, it supports the early phases of drug discovery and the development of biochemical tools targeting proteolytic pathways.
Mechanistic Enzymology: Researchers employ this substrate in mechanistic studies to dissect the catalytic mechanisms of serine and cysteine proteases. The defined peptide sequence and predictable cleavage site allow for precise investigation of substrate recognition, active site preferences, and transition state stabilization. Such experiments yield critical insights into enzyme-substrate interactions and inform rational design of modified substrates or inhibitors.
Cell-Free Proteolysis Models: In cell-free systems, the peptide-AMC conjugate is used to simulate proteolytic events under controlled conditions, enabling the study of protease regulation, activation, and inhibition outside the complexity of living cells. This application is particularly valuable for elucidating the effects of cofactors, post-translational modifications, or environmental variables on protease function, thereby advancing understanding of proteolytic control mechanisms.
Analytical Method Development: The substrate's fluorogenic properties are leveraged in the development and validation of analytical assays for protease quantification in complex biological mixtures. Its sensitivity and specificity make it suitable for applications such as quality control of enzyme preparations, assessment of protease contamination in biochemical workflows, and optimization of assay protocols for research or industrial purposes. The versatility and reliability of L-Ala-Ala-Phe-7-Amido-4-methylcoumarin Tfa salt have established its role as a key reagent in modern peptide biochemistry and enzymology.
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.